Get Free Access
TZ Ref No.: TZ-1132564

Medicines for the treatment of diseases of the blood, blood-forming organs and diseases of the cardiovascular system, namely: epinephrine 1.82 mg/ml, solution for injection, ampoule; aminocaproic acid, solution for infusion, 50 mg/ml, 100 ml...

Doc ref no. -
Sector Pharmaceuticals, Healthcare and Medicine, Chemicals
Publish Date 01 Oct 2026
Estimated Value UAH 65K
Tender Intelligence
Qualification analysis + key highlights for this procurement

TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

Sign in to unlock Bid Fit & AI Opportunity Intelligence

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Description & Project Overview

Medicines for the treatment of diseases of the blood, blood-forming organs and diseases of the cardiovascular system, namely: epinephrine 1.82 mg/ml, solution for injection, ampoule; aminocaproic acid, solution for infusion, 50 mg/ml, 100 ml each; amiodarone, solution for injection, 50 mg/ml, 3 ml each; metamizole sodium, solution for injection, 500 mg/ml, 2 ml; potassium aspartate/magnesium aspartate solution for injection 5 ml each; atropine sulfate solution for injection 1 mg/1 ml, in 1 ml ampoule; acetylsalicylic acid tablets 500 mg each; barbiturates in combination (ethyl ester of alpha-bromoisovaleric acid 18 mg, phenobarbital 17 mg, solution of menthol in menthyl ester of isovaleric acid 80 mg) oral drops 25 ml each; heparin sodium, solution for injection, 5000 IU/ml, 5 ml each; glucose solution for injection 40% 20 ml each; glucose solution for infusion 5% 200 ml each; dexamethasone, solution for injection 4 mg/ml; dexketoprofen solution for injection 25 mg/ml 2 ml each; diclofenac solution for injection 25 mg/ml; diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; drotaverine solution for injection 20 mg/ml, 2 ml in ampoule; isosorbide, spray, 1.25 mg/dose, 15 ml each; paracetamol solution for infusion 10 mg/ml 100 ml; calcium gluconate solution for injection 100 mg/ml 5 ml each; captopril/hydrochlorothiazide, tablets, 50/12.5 mg each; ketorolac solution for injection, 30 mg/ml, 1 ml each; caffeine sodium benzoate, solution for injection, 100 mg/ml, 1 ml each; chloramphenicol/methyluracil ointment 7.5 mg/40 mg 40 g each; lidocaine, solution for injection, 100 mg/ml, 2 ml each; lidocaine, spray, 10%, 38 g each; balsamic liniment according to Vishnevsky 40 g each; magnesium sulfate, solution for injection, 250 mg/ml, 10 ml each; hydrocortisone butyrate, cream, 1 mg/g, 30 g each; metoclopramide, solution for injection, 5 mg/ml, 2 ml each; sodium thiosulfate solution for injection 300 mg/ml 5 ml; sodium chloride, solution for infusion, 9 mg/ml 200 ml; sodium chloride, solution for injection, 9 mg/ml, 5 ml each; ondansetron solution for injection 2 mg/ml 2 ml each; papaverine, solution for injection, 20 mg/ml, 2 ml each; hydrogen peroxide, solution, 3%, 100 ml each; piracetam, solution for injection, 200 mg/ml, 5 ml each; platyphyllin solution for injection, 2 mg/ml, 1 ml each; dabigatran etexilate hard capsules 150 mg each; prednisolone, solution for injection, 30 mg/ml, 1 ml each; electrolytes in combination with sorbitol 60 mg/1 ml solution for infusion 200 ml each; inosine, solution for injection, 20 mg/ml, 10 ml each; salbutamol, pressurised inhalation, 100 mcg/dose, 200 doses each; dexpanthenol cutaneous foam 50 mg/g 116 g each; sulfacamphocaine solution for injection, 100 mg/ml 2 ml each; chloropyramine, solution for injection, 20 mg/ml, 1 ml each; furosemide, solution for injection, 10 mg/ml, 2 ml each; tranexamic acid solution for injection, 100 mg/ml 5 ml each; Trisol solution for infusion 200 ml each; chlorhexidine, solution for external use 0.05% 100 ml each; theophylline solution for injection 20 mg/ml 5 ml each

Days to Deadline
13 days
Closing: 31 Oct 2026, 00:00

Consortium & JV Partners

Matched
Need a Co-Bidder or Subcontractor?

Forming a Joint Venture increases technical eligibility and financial bonding capacity.

Post / Find JV Partners →

Key Procurement Details

Doc ref no. -
Notice Type Tender Notice
Bidding Type N/A
Publish Date 01 Oct 2026
Sector Pharmaceuticals, Healthcare and Medicine, Chemicals
Document Fee Available in full notice
Bid Security Refer to documents
Funding Government Budget
Bid Opening Locked

Buyer Contact Information

Contact Details Locked

Nodal officer email, telephone, and website coordinates are unlocked upon free sign up.

Unlock Contact Details (Free) →